Mostly Resilient
Last Update: 8/30/2026
AI Resilience Score for Cytotechnologists:
51.9%
Median Score
Meaningful human contribution
Measures the parts of the occupation that still require a human touch. This score averages data from up to four AI exposure datasets, focusing on the role’s resilience against automation.
Med
Long-term employer demand
Predicts the health of the job market for this role through 2034. Using Bureau of Labor Statistics data, it balances projected annual job openings (60%) with overall employment growth (40%).
Med
Sustained economic opportunity
Measures future earning potential and career flexibility. This score is a blend of total projected labor income (67%) and the role’s inherent ability to adapt to economic and technological shifts (33%).
Med
This reflects the reliability of your score based on the number of data sources available for this career and how closely those sources agree on the outlook. A higher confidence means more consistent evidence from labor experts and AI models.
There are a reasonable number of sources for this result, but there is some disagreement between them.
Contributing sources
AI Resilience Report forCytotechnologists
$62,930 median salary•20,800 annual openings•SOC Code: 29-2011.02
Cytotechnologists are somewhat more resilient to AI impacts than most occupations, according to our analysis of 5 sources.
Cytotechnologists are labeled "Mostly Resilient" because AI is stepping in as a helpful partner rather than a replacement, handling the repetitive task of pre-screening slides and flagging suspicious cells so that human experts can focus on the complex, high-stakes cases that truly need trained judgment. Tools like Hologic's Genius Cervical AI are FDA-cleared to assist with interpreting Pap tests, but a cytotechnologist still makes the final call, which means the most important part of the job stays firmly in human hands.
Learn more about how you can thrive in this position
View analysis
Chat with Coach
Latest news
More career infoAnalysisChatNewsMoreThis role is mostly resilient
Cytotechnologists are labeled "Mostly Resilient" because AI is stepping in as a helpful partner rather than a replacement, handling the repetitive task of pre-screening slides and flagging suspicious cells so that human experts can focus on the complex, high-stakes cases that truly need trained judgment. Tools like Hologic's Genius Cervical AI are FDA-cleared to assist with interpreting Pap tests, but a cytotechnologist still makes the final call, which means the most important part of the job stays firmly in human hands.
Read full analysisLearn more about how you can thrive in this position
View analysisChat with CoachLatest newsMore career infoAnalysisChatNewsMoreAnalysis of Current AI Resilience
Cytotechnologists
Updated Quarterly
How is AI changing Cytotechnologists jobs?
Good news first: AI in this field is mostly augmenting cytotechnologists rather than replacing them. The clearest example is Hologic's Genius Digital Diagnostics System, the first FDA-cleared digital cytology system using AI and advanced imaging, which promises improved sensitivity in detecting pre-cancerous lesions and cervical cancer cells, described in Contemporary OB/GYN [1]. A regulatory review by Innolitics [2] notes there are now FDA-authorized cytology tools including Hologic's Genius Cervical AI, which assists cytotechnologists in interpreting ThinPrep Pap tests.
According to CAP TODAY [3], gynecologic cytology continues to lead digital and AI adoption, with deep-learning platforms that classify cells and flag high-risk fields of view, while urine and thyroid cytology are next in line. Importantly, CytoJournal [4] explains that these systems combine algorithm-guided field review with human expertise, underscoring the capability of digital augmentation to enhance cytologic interpretation. So AI is doing pre-screening and highlighting suspicious cells, but a trained human still makes the call.
Sources
How fast is AI adoption growing for Cytotechnologists?
Adoption is being pushed forward by a real workforce squeeze. Labcorp [5] reports that an aging pathology workforce is nearing retirement, residency positions are unfilled, case volumes are rising, and burnout is escalating across teams already stretched thin. The Pathologist [6] similarly notes that rising cancer incidence, growing demand for molecular testing, and a persistent pathologist shortage have been straining cytology services nationwide.
That economic pressure makes AI attractive — it can extend expert coverage without requiring more people. On the slower side, cytology AI is regulated as a medical device, meaning every new tool needs rigorous FDA validation before hospitals will trust it. Human skills like fine-needle-aspiration assistance, patient interaction, equipment troubleshooting, and pathologist collaboration remain hard to automate.
If you're considering this career, the realistic picture is a partnership with AI: it will handle the repetitive screening, and you'll focus on the tricky, high-judgment cases that matter most for patients.
Sources
Will AI replace Cytotechnologists?
No. We don't think AI will replace Cytotechnologists, though we do expect the job to change.
Cytotechnologists earn a 51.9% AI Resilience Score from us, landing in "Mostly Resilient" territory. That reflects a real but manageable shift: AI is moving into this field, but it's mostly working alongside cytotechnologists rather than pushing them out.
The clearest sign of that partnership is tools like Hologic's Genius Digital Diagnostics System, the first FDA-cleared AI-assisted digital cytology platform, which helps flag suspicious cells and improve detection of pre-cancerous lesions [1]. Deep-learning platforms are also classifying cells and highlighting high-risk fields of view in gynecologic cytology, with urine and thyroid applications coming next [3]. But these systems combine algorithm-guided review with human expertise, not human expertise alone [4]. A trained cytotechnologist still makes the final call.
There's also a workforce reality pushing demand forward rather than down. An aging pathology workforce, unfilled residency positions, rising case volumes, and growing burnout are all straining cytology services [5]. AI helps stretch expert coverage, but it doesn't eliminate the need for skilled humans. Skills like fine-needle-aspiration assistance, pathologist collaboration, and patient interaction remain genuinely hard to automate. This career is changing, not disappearing.
Sources
Help us improve this report.
Tell us if this analysis feels accurate or we missed something.
Share your feedback
Latest AI news for Cytotechnologists
These articles highlight the evolving role of cytotechnologists in an AI-driven landscape. For instance, the first article indicates a 78/100 AI replacement risk, emphasizing the need for cytotechnologists to adapt as tasks like Pap smear screening become increasingly automatable. Moreover, by 2028, nearly half of their tasks may be automated, according to another source. While job numbers may decline, embracing AI-assisted workflows can enhance skills and resilience, ensuring cytotechnologists remain valuable in diagnostics. Understanding these trends will help students prepare for a future where they work alongside AI rather than be replaced by it.
Cytotechnologists & AI: 78/100 Replacement Risk
www.aijobchecker.com • 8/20/2026
Cytotechnologists face a 78/100 AI replacement risk. Pap smear screening is 91% automatable now. See task-by-task risk data and how to future-proof your...
Will AI Replace Cytotechnologist Jobs?
jobzonerisk.com • 8/20/2026
Mid-level cytotechnologists will transition from full-slide manual screening to AI-assisted review workflows. The number of cytotechs needed will decline. ...
AI Impact on Cytotechnologists: Timeline & Survival
myjobvsai.com • 8/20/2026
By 2028, approximately 45% of Cytotechnologist tasks will be automated by AI-powered diagnostic imaging systems.
Will AI Replace Cytotechnologists?
aitakeovertracker.com • 8/20/2026
Cytotechnologists : Medium AI risk (score: 39/100, higher than 78% of occupations). Full task-by-task breakdown, skill gaps, and career alternatives.
Are y'all worried that AI will take over the cytotechnology ...
www.reddit.com • 8/20/2026
Bottom line, the field is going to continue getting smaller with fewer techs and places to work. I think everyone can agree on that. The ... Read more
More Career Info
Career: Cytotechnologists
They examine cell samples under a microscope to find signs of diseases like cancer, helping doctors make accurate diagnoses.
Parent Careers
Similar Careers
Employment & Wage Data
* Data estimated from parent occupation
Median Wage
$62,930
Jobs (2025)
343,000
Growth (2025-35)
+2.7%
Annual Openings
20,800
Education
Bachelor's degree
Experience
None
Source: Bureau of Labor Statistics, Employment Projections 2025-2035
Task-Level AI Resilience Scores
AI-generated estimates of task resilience over the next 3 years
1
Assist pathologists or other physicians to collect cell samples by fine needle aspiration (FNA) biopsy or other method.
2
Adjust, maintain, or repair laboratory equipment, such as microscopes.
3
Attend continuing education programs that address laboratory issues.
4
Assign tasks or coordinate task assignments to ensure adequate performance of laboratory activities.
5
Provide patient clinical data or microscopic findings to assist pathologists in the preparation of pathology reports.
6
Prepare cell samples by applying special staining techniques, such as chromosomal staining, to differentiate cells or cell components.
7
Prepare and analyze samples, such as Papanicolaou (PAP) smear body fluids and fine needle aspirations (FNAs), to detect abnormal conditions.
Tasks are ranked by their AI resilience, with the most resilient tasks shown first. Core tasks are essential functions of this occupation, while supplemental tasks provide additional context.
